Caplin Point Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Caplin Point Laboratories Ltd. from all sources in a single place.

Load latest

Caplin Point Laboratories Ltd.

29 Oct 2025

1921.90

0.18%

Board Meeting

Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Considering And Approving, Inter-Alia, The …

BSE India

Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter and half-year ended September 30, 2025

pdf

Caplin Point Laboratories Ltd.

23 Oct 2025

1921.90

0.18%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release - Receipt of USFDA approval and recent acquisition of third party ANDAs

pdf

Caplin Point Laboratories Ltd.

04 Oct 2025

1921.90

0.18%

Company Update

Caplin Point Laboratories Ltd - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

pdf

Caplin Point Laboratories Ltd.

29 Sep 2025

1921.90

0.18%

SAST

Caplin Point Laboratories Ltd - 524742 - Closure of Trading Window

BSE India

Closure of Trading Window

pdf

Caplin Point Laboratories Ltd.

23 Sep 2025

1921.90

0.18%

AGM

Caplin Point Laboratories Ltd - 524742 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Voting Results and Scrutinizer Report for the 34th Annual General Meeting

pdf

Caplin Point Laboratories Ltd.

22 Sep 2025

1921.90

0.18%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation of Appointment of Secretarial Auditor of the Company

pdf

Caplin Point Laboratories Ltd.

22 Sep 2025

1921.90

0.18%

AGM

Caplin Point Laboratories Ltd - 524742 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Proceedings of 34th Annual General Meeting of the Company

pdf

Caplin Point Laboratories Ltd.

03 Sep 2025

1921.90

0.18%

Caplin Point's unit gets USFDA nod for generic milrinone lactate injection

Business Standard

Pharma firm Caplin Point Laboratories Ltd on Wednesday said its arm Caplin Steriles Ltd has received final approval from the US health regulator for its generic milrinone lactate in 5 per cent dextrose injection indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) milrinone lactate in 5 per cent Dextrose Injection of strengths 20 mg/100 mL and 40 mg/200 mL in single-dose infusion bags, Caplin Point Laboratories said in a regulatory filing. The approved injection is a generic therapeutic equivalent version of the reference listed drug PRIMACOR in dextrose 5 per cent, by Sanofi Aventis US LLC, it added. Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure, the company said. Citing IQVIA (IMS Health) data, the company said milrinone lactate in 5 per cent...